The Quick Answer AOD-9604 is a 17-amino-acid synthetic peptide consisting of the C-terminal fragment of human growth hormone (residues 176-191) plus an N-terminal tyrosine modification
References The Lancet (2023) Rosenstock J, et al
Backed by emerging research and physiologic mechanisms, these peptides support: AlyneMDs longevity program integrates scientifically validated peptides with diagnostics, hormone balance, and metabolic optimization to support patients across New Jersey and New York seeking next-generation age management
Published work on intranasal peptide delivery (for insulin analogs, calcitonin, and oxytocin) demonstrates that bioavailability for this size class without enhancers is typically in the low single-digit percent range, though these data are from different peptides with different charge profiles
As we age, acid production declines